CAT and benign prostatic hyperplasia: As a result, EGCG increased the prostatic activities of antioxidant enzymes (SOD, GPx, and CAT) and the levels of non-enzymatic antioxidants (GSH and TSH), and it reduced the level of MDA, which is recognized as a lipid peroxidation marker, in BPH rats [107].